180 related articles for article (PubMed ID: 28982897)
1. Interfractional Rectal Displacement Requiring Repeated Precaution Did Not Correlate to Biochemical Control and Rectal Toxicity in Patients with Prostate Cancer Treated with Image-guided Intensity-modulated Radiation Therapy.
Iwama K; Yamazaki H; Shimizu D; Suzuki G; Nakamura S; Sasaki N; Takeneka T; Okabe H; Nishikawa T; Yoshida K
Anticancer Res; 2017 Oct; 37(10):5755-5760. PubMed ID: 28982897
[TBL] [Abstract][Full Text] [Related]
2. Frequency and predisposing factors for interfractional rectal displacement requiring repeated precaution in prostate cancer patients treated with image-guided intensity-modulated radiation therapy.
Iwama K; Yamazaki H; Nishimura T; Oota Y; Aibe N; Nakamura S; Ikeno H; Yoshida K; Okabe H
Anticancer Res; 2014 Dec; 34(12):7373-8. PubMed ID: 25503175
[TBL] [Abstract][Full Text] [Related]
3. Long-term Tumor Control and Late Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft-tissue-matched Image-guided Intensity-modulated Radiotherapy.
Shimizu D; Yamazaki H; Nishimura T; Aibe N; Okabe H
Anticancer Res; 2017 Oct; 37(10):5829-5835. PubMed ID: 28982908
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
[TBL] [Abstract][Full Text] [Related]
5. Current status of intensity-modulated radiation therapy for prostate cancer: History, clinical results and future directions.
Hatano K; Tohyama N; Kodama T; Okabe N; Sakai M; Konoeda K
Int J Urol; 2019 Aug; 26(8):775-784. PubMed ID: 31115116
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer.
Tsubokura T; Yamazaki H; Masui K; Sasaki N; Shimizu D; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Nishikawa T; Okabe H
Sci Rep; 2018 Jul; 8(1):10538. PubMed ID: 30002393
[TBL] [Abstract][Full Text] [Related]
7. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.
Sveistrup J; af Rosenschöld PM; Deasy JO; Oh JH; Pommer T; Petersen PM; Engelholm SA
Radiat Oncol; 2014 Feb; 9():44. PubMed ID: 24495815
[TBL] [Abstract][Full Text] [Related]
8. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
[TBL] [Abstract][Full Text] [Related]
9. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939
[TBL] [Abstract][Full Text] [Related]
10. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
[TBL] [Abstract][Full Text] [Related]
11. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.
Wortel RC; Incrocci L; Pos FJ; Lebesque JV; Witte MG; van der Heide UA; van Herk M; Heemsbergen WD
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):737-44. PubMed ID: 25752386
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcomes of a Dose-reduction Trial to Decrease Late Gastrointestinal Toxicity in Patients with Prostate Cancer Receiving Soft Tissue-matched Image-guided Intensity-modulated Radiotherapy.
Sasaki N; Yamazaki H; Shimizu D; Suzuki G; Masui K; Nakamura S; Okabe H; Nishikawa T; Yoshida K
Anticancer Res; 2018 Jan; 38(1):385-391. PubMed ID: 29277799
[TBL] [Abstract][Full Text] [Related]
13. Local Protocol Variations for Image Guided Radiation Therapy in the Multicenter Dutch Hypofractionation (HYPRO) Trial: Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels.
Wortel RC; Heemsbergen WD; Smeenk RJ; Witte MG; Krol SDG; Pos FJ; Incrocci L
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1243-1252. PubMed ID: 28943074
[TBL] [Abstract][Full Text] [Related]
14. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
[TBL] [Abstract][Full Text] [Related]
15. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
[TBL] [Abstract][Full Text] [Related]
16. Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer.
Zelefsky MJ; Pinitpatcharalert A; Kollmeier M; Goldman DA; McBride S; Gorovets D; Zhang Z; Varghese M; Happersett L; Tyagi N; Hunt M
Eur Urol Oncol; 2020 Dec; 3(6):748-755. PubMed ID: 31668713
[TBL] [Abstract][Full Text] [Related]
17. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
Bridges D; Kawamura H; Kanai T
PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
[TBL] [Abstract][Full Text] [Related]
18. Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.
Bohrer M; Schröder P; Welzel G; Wertz H; Lohr F; Wenz F; Mai SK
Strahlenther Onkol; 2008 Dec; 184(12):674-8. PubMed ID: 19107349
[TBL] [Abstract][Full Text] [Related]
19. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
[TBL] [Abstract][Full Text] [Related]
20. Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.
Leiker AJ; Desai NB; Folkert MR
Future Oncol; 2018 Nov; 14(26):2773-2788. PubMed ID: 29939069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]